AUSTIN, Texas, Aug. 10, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that the company's leadership will participate in several upcoming investor conferences.

Steve Chapman, chief executive officer, and Mike Brophy, chief financial officer, will discuss recent business activities, the continued and significant growth of Natera in the genetic testing industry and the impact the company is making on people's lives.

Details are as follows:

Canaccord Genuity 41st Annual Growth Conference

Wells Fargo Healthcare Conference 2021

Morgan Stanley 19^th Annual Global Healthcare Conference

Baird Global Healthcare Conference 2021

Access to the live webcasts and subsequent archived presentations will be available at investor.natera.com.

About Natera
Natera is a pioneer and global leader in cell-free DNA testing from a simple blood draw. The mission of the company is to change the management of disease worldwide with a focus on women's health, oncology, and organ health. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas and San Carlos, California. It offers proprietary genetic testing services to inform obstetricians, transplant physicians, oncologists, and cancer researchers, including biopharmaceutical companies, and genetic laboratories through its cloud-based software platform. For more information, visit natera.com. Follow Natera on LinkedIn.

Contacts

Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-826-2350
Media: Kate Stabrawa, Communications, Natera, Inc., pr@natera.com     

View original content to download multimedia:https://www.prnewswire.com/news-releases/natera-to-participate-in-upcoming-investor-conferences-301351743.html

SOURCE Natera, Inc.